Facebook Twitter Youtube Linkedin
The Regulatory Review

The Debate over a New ALS Drug Harkens Back to the Aduhelm Controversy

Twitter Facebook Linkedin Envelope Link
Font Size:

Holly Fernandez Lynch in Washington Post, Sep 8, 2022

(Visited 33 times, 1 visits today)

Subscribe to Updates

Contact Info

Penn Program on Regulation
University of Pennsylvania Carey Law School
3501 Sansom Street
Philadelphia, Pennsylvania 19104
regulation@law.upenn.edu

Program Director
Cary Coglianese
+1 215.898.6867

Links

Facebook Twitter Youtube Linkedin

Research Search

Site Map

Privacy Notice

The Regulatory Review
Penn Law

©2022 University of Pennsylvania Carey Law School

Site by Capital Technology Services